These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15606325)

  • 1. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
    Iqbal S; Lenz HJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New options for outpatient chemotherapy--the role of oral fluoropyrimidines.
    Cunningham D; Coleman R
    Cancer Treat Rev; 2001 Aug; 27(4):211-20. PubMed ID: 11545541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of capecitabine dosing in colorectal cancer.
    Sun W
    Clin Colorectal Cancer; 2010 Jan; 9(1):31-9. PubMed ID: 20100686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine plus oxaliplatin for the treatment of colorectal cancer.
    Carrato A; Gallego-Plazas J; Guillén-Ponce C
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):161-74. PubMed ID: 18279056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.
    Van Cutsem E; Verslype C; Tejpar S
    Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
    Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy.
    Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M
    J BUON; 2010; 15(4):652-9. PubMed ID: 21229625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of capecitabine in the treatment of colorectal cancer in the elderly.
    Pasetto LM; Monfardini S
    Anticancer Res; 2006; 26(3B):2381-6. PubMed ID: 16821620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.
    McGavin JK; Goa KL
    Drugs; 2001; 61(15):2309-26. PubMed ID: 11772141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials.
    Arkenau HT; Arnold D; Cassidy J; Diaz-Rubio E; Douillard JY; Hochster H; Martoni A; Grothey A; Hinke A; Schmiegel W; Schmoll HJ; Porschen R
    J Clin Oncol; 2008 Dec; 26(36):5910-7. PubMed ID: 19018087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Capecitabine].
    Yamaguchi K; Shimamura T; Tada M
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):891-5. PubMed ID: 16835474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oral chemotherapy in colorectal cancer.
    Donehower RC
    Oncology (Williston Park); 2000 Nov; 14(11A):243-5. PubMed ID: 11195416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.
    Pandor A; Eggington S; Paisley S; Tappenden P; Sutcliffe P
    Health Technol Assess; 2006 Nov; 10(41):iii-iv, xi-xiv, 1-185. PubMed ID: 17049138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
    Ajani J
    Cancer; 2006 Jul; 107(2):221-31. PubMed ID: 16770784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is XELOX equivalent to FOLFOX or other continuous-infusion 5-fluorouracil chemotherapy in metastatic colorectal cancer?
    Douillard JY; Bennouna J; Senellart H
    Clin Colorectal Cancer; 2008 May; 7(3):206-11. PubMed ID: 18621641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine/irinotecan combination regimens in colorectal cancer.
    Kerr DJ
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):27-9. PubMed ID: 12014865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
    Comella P; Natale D; Farris A; Gambardella A; Maiorino L; Massidda B; Casaretti R; Tafuto S; Lorusso V; Leo S; Cannone M
    Cancer; 2005 Jul; 104(2):282-9. PubMed ID: 15948167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.